Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries United Therapeutic (NQ: UTHR ) 363.55 +3.33 (+0.92%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about United Therapeutic < Previous 1 2 3 4 5 6 7 8 9 Next > United Therapeutics Provides an Update on Its Organ Printing Programs June 06, 2022 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation to Present at the Jefferies Healthcare Conference June 03, 2022 From United Therapeutics Corporation Via Business Wire Short Volatility Alert: United Therapeutics Corporation May 26, 2022 On Wednesday, shares of United Therapeutics Corporation (NASDAQ: UTHR) experienced volatile short activity. After the activity, the stock price went up 4.31% to $228.39. The... Via Benzinga United Therapeutics Stock Sees RS Rating Jump To 89; Earns 'Blue Dot' May 24, 2022 United Therapeutics stock had its Relative Strength (RS) Rating upgraded to 89 Tuesday, from 71 a day earlier. Via Investor's Business Daily Expert Ratings for United Therapeutics May 24, 2022 Within the last quarter, United Therapeutics (NASDAQ:UTHR) has observed the following analyst ratings: Via Benzinga The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures May 24, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga United Therapeutics Announces FDA Approval of Tyvaso DPI™ May 24, 2022 From United Therapeutics Corporation Via Business Wire United Therapeutics's Return on Invested Capital Insights May 18, 2022 According to Benzinga Pro, during Q1, United Therapeutics (NASDAQ:UTHR) earned $239.90 million, a 113.81% increase from the preceding quarter. United Therapeutics also posted a total of $461.90 million... Via Benzinga 7 Biotech Stocks With Key Catalysts for May May 11, 2022 The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns. Via InvestorPlace The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints May 04, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga Recap: United Therapeutics Q1 Earnings May 04, 2022 United Therapeutics (NASDAQ:UTHR) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga United Therapeutics Corporation Reports First Quarter 2022 Financial Results May 04, 2022 From United Therapeutics Corporation Via Business Wire Earnings Scheduled For May 4, 2022 May 04, 2022 Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million. Via Benzinga Earnings Outlook For United Therapeutics May 03, 2022 United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that United... Via Benzinga United Therapeutics Q1 2022 Earnings Conference Call On May 4, 2022 At 09:00 AM ET April 29, 2022 United Therapeutics (NASDAQ:UTHR) will host a conference call at 09:00 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. How to Attend United Therapeutics (UTHR) Conference Call Follow this... Via Benzinga United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the 2022 American Thoracic Society International Conference April 29, 2022 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation to Report First Quarter 2022 Financial Results Before the Market Opens on Wednesday, May 4, 2022 April 27, 2022 From United Therapeutics Corporation Via Business Wire United Therapeutics Announces the Publication of Tyvaso DPI™ BREEZE Clinical and Long-term Data in the Journal Pulmonary Circulation April 06, 2022 From United Therapeutics Corporation Via Business Wire First Human With Pig Heart Transplant Dies: Reuters March 09, 2022 A 57-year-old man with terminal heart disease who became the first person to receive a genetically modified pig's heart has died, the University of Maryland Medical... Via Benzinga 10 Biggest Price Target Changes For Monday February 28, 2022 Barclays cut the price target on MasTec, Inc. (NYSE: MTZ) from $140 to $120. MasTec shares fell 0.1% to $79.00 in pre-market trading. Via Benzinga Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease February 28, 2022 PH-ILD is a rare, serious, and progressive illness without an approved treatment in Europe and many other parts of the world Via Newswire.com United Therapeutics Earnings Perspective: Return On Capital Employed February 25, 2022 Pulled from Benzinga Pro data, United Therapeutics (NASDAQ:UTHR) posted Q4 earnings of $112.20 million, an increase from Q3 of 31.04%. Sales dropped to $415.20 million, a 6.63%... Via Benzinga FDA Pushes United Therapeutics-MannKind Tyvaso DPI's Decision Date; United Therapeutics' Q4 Misses Consensus February 24, 2022 United Therapeutics Corp (NASDAQ: UTHR) and its partner MannKind Corp (NASDAQ: MNKD) have received an FDA information request letter for additional... Via Benzinga United Therapeutics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results February 24, 2022 From United Therapeutics Corporation Via Business Wire United Therapeutics's Earnings Outlook February 23, 2022 United Therapeutics (NASDAQ:UTHR) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts... Via Benzinga United Therapeutics Corporation to Report Fourth Quarter and Full Year 2021 Financial Results Before the Market Opens on Thursday, February 24, 2022 February 21, 2022 From United Therapeutics Corporation Via Business Wire United Therapeutics Corporation Announces Historic Achievements in its Xenotransplantation Programs January 21, 2022 From United Therapeutics Corporation Via Business Wire First Successful Pig Heart Transplant Into Human: Details On The Amazing Technology And A Public Company To Watch January 11, 2022 Pigs may not be able to fly, but they've provided a vital organ in a life-saving surgery for one U.S. man. What Happened: A Maryland hospital completed the first... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session January 11, 2022 Gainers Black Diamond Therapeutic (NASDAQ:BDTX) stock increased by 18.2% to $5.32 during Tuesday's pre-market session. The market value of their outstanding shares is... Via Benzinga 7 Pharmaceutical Stocks That Could Make You Rich January 06, 2022 Due to expiring patents and rising competition, successful pharmaceutical stocks need to develop robust drug pipelines. 7 Pharmaceutical Stocks That Could Make You Rich Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.